Physician profile
Adam Derhake
NPI 1679741151
$20,901.74
in general payments reported to CMS, 2019-2025
11 companies · $2,004 in 2025
The $2,004 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,383 · 2020: $1,294 · 2021: $8,604 · 2022: $2,547 · 2023: $163 · 2024: $907 · 2025: $2,004.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,128 · Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,128.25 |
| Food and Beverage | $945.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $10,779.63 | 2019-2025 | |
| Arthrex, INC. | $6,624.43 | 2019-2025 | |
| Steris Corporation | $2,996.43 | 2019 | |
| Amgen INC. | $249.06 | 2022-2025 | Evenity, Prolia |
| Ferring Pharmaceuticals INC. | $104.43 | 2021-2025 | Euflexxa |
| Biocomposites INC | $37.74 | 2025 | Stimulan |
| Bioventus LLC | $27.99 | 2022-2023 | Exogen Ultrasound Bone Healing System |
| Pacira Pharmaceuticals Incorporated | $24.99 | 2025 | Exparel |
| Radius Health, INC. | $22.65 | 2024 | Tymlos |
| Pacira Therapeutics, INC. | $20.92 | 2020 | |
| Karl Storz Endoscopy-America | $13.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Derhake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.